• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用心肺磁共振评估囊性纤维化中的心脏受累情况。

Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance.

作者信息

Lagan Jakub, Naish Josephine H, Bradley Joshua, Fortune Christien, Palmer Charlie, Clark David, Schelbert Erik B, Schmitt Matthias, Bright-Thomas Rowland, Miller Christopher A

机构信息

Manchester University NHS Foundation Trust, Wythenshawe Hospital, Southmoor Road, Wythenshawe, Manchester, M23 9LT, England, UK.

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England, UK.

出版信息

Int J Cardiovasc Imaging. 2022 May;38(5):1121-1131. doi: 10.1007/s10554-021-02496-6. Epub 2022 Jan 7.

DOI:10.1007/s10554-021-02496-6
PMID:34994881
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9116982/
Abstract

Cystic fibrosis (CF) transmembrane conductance regulator is expressed in myocardium, but cardiac involvement in CF remains poorly understood. The recent development of a combined cardiopulmonary magnetic resonance imaging technology allows for a simultaneous interrogation of cardiac and pulmonary structure and function. The aim of this study was to investigate myocardial manifestations in adults with CF, both in a stable state and during an acute respiratory exacerbation, and to investigate the relationship between cardiac and pulmonary disease. Healthy adult volunteers (n = 12) and adults with CF (n = 10) were studied using a multiparametric cardiopulmonary magnetic resonance protocol. CF patients were scanned during an acute respiratory exacerbation and re-scanned when stable. Stable CF was associated with left ventricular dilatation and hypertrophy (LVH; left ventricular mass: CF 59 ± 9 g/m vs. control 50 ± 8 g/m; p = 0.028). LVH was predominantly driven by extracellular myocardial matrix expansion (extracellular matrix mass: CF 27.5 ± 3.4 g vs. control 23.6 ± 5.2 g; p = 0.006; extracellular volume [ECV]: CF 27.6 [24.7-29.8]% vs. control 24.8 [22.9-26.0]%; p = 0.030). Acute CF was associated with an acute reduction in left ventricular function (ejection fraction: acute 57 ± 3% vs. stable 61 ± 5%; p = 0.025) and there was a suggestion of myocardial oedema. Myocardial oedema severity was strongly associated with the severity of airflow limitation (r = - 0.726, p = 0.017). Multiparametric cardiopulmonary magnetic resonance technology allows for a simultaneous interrogation of cardiac and pulmonary structure and function. Stable CF is associated with adverse myocardial remodelling, including left ventricular systolic dilatation and hypertrophy, driven by myocardial fibrosis. CF exacerbation is associated with acute myocardial contractile dysfunction. There is also a suggestion of myocardial oedema in the acute period which is related to pulmonary disease severity.

摘要

囊性纤维化(CF)跨膜传导调节因子在心肌中表达,但CF患者的心脏受累情况仍知之甚少。最近开发的心肺联合磁共振成像技术能够同时检测心脏和肺部的结构与功能。本研究的目的是调查CF成年患者在稳定状态和急性呼吸加重期的心肌表现,并研究心脏与肺部疾病之间的关系。使用多参数心肺磁共振成像方案对健康成年志愿者(n = 12)和CF成年患者(n = 10)进行了研究。CF患者在急性呼吸加重期进行扫描,并在病情稳定时再次扫描。稳定期CF与左心室扩张和肥厚(LVH;左心室质量:CF组59±9 g/m vs.对照组50±8 g/m;p = 0.028)相关。LVH主要由细胞外心肌基质扩张驱动(细胞外基质质量:CF组27.5±3.4 g vs.对照组23.6±5.2 g;p = 0.006;细胞外容积[ECV]:CF组27.6[24.7 - 29.8]% vs.对照组24.8[22.9 - 26.0]%;p = 0.030)。急性CF与左心室功能急性下降相关(射血分数:急性发作期57±3% vs.稳定期

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/60f4129da690/10554_2021_2496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/82780dbf025f/10554_2021_2496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/ae3738a37bee/10554_2021_2496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/c64d94b19521/10554_2021_2496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/60f4129da690/10554_2021_2496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/82780dbf025f/10554_2021_2496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/ae3738a37bee/10554_2021_2496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/c64d94b19521/10554_2021_2496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be2/9116982/60f4129da690/10554_2021_2496_Fig4_HTML.jpg

相似文献

1
Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance.使用心肺磁共振评估囊性纤维化中的心脏受累情况。
Int J Cardiovasc Imaging. 2022 May;38(5):1121-1131. doi: 10.1007/s10554-021-02496-6. Epub 2022 Jan 7.
2
Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance.采用心肺磁共振评估嗜酸性肉芽肿性多血管炎的心肌受累情况。
Int J Cardiovasc Imaging. 2021 Apr;37(4):1371-1381. doi: 10.1007/s10554-020-02091-1. Epub 2020 Nov 19.
3
Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy.高血压合并心肌病小鼠模型中心肌肥厚和心肌纤维化的进展和消退。
J Cardiovasc Magn Reson. 2020 Aug 6;22(1):57. doi: 10.1186/s12968-020-00655-7.
4
Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass.弥漫性心肌纤维化降低左心室肥厚的心电图电压测量值,且独立于左心室质量。
J Am Heart Assoc. 2017 Jan 22;6(1):e003795. doi: 10.1161/JAHA.116.003795.
5
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.T1 测量可识别肥厚型心肌病肌节突变携带者有无左心室肥厚的细胞外容积扩张。
Circ Cardiovasc Imaging. 2013 May 1;6(3):415-22. doi: 10.1161/CIRCIMAGING.112.000333. Epub 2013 Apr 2.
6
Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.高血压性心脏病左心室表型的综合特征分析
Heart. 2016 Oct 15;102(20):1671-9. doi: 10.1136/heartjnl-2016-309576. Epub 2016 Jun 3.
7
Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.利用磁共振成像技术识别 COVID-19 康复患者的心脏受累情况。
JACC Cardiovasc Imaging. 2020 Nov;13(11):2330-2339. doi: 10.1016/j.jcmg.2020.05.004. Epub 2020 May 12.
8
Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.在非缺血性心肌病中,细胞外容积分数比左心室射血分数与左心室局部速度改变的相关性更强。
Circ Cardiovasc Imaging. 2014 Dec 31;8(1). doi: 10.1161/CIRCIMAGING.114.001998. Print 2015 Jan.
9
ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study.高血压患者的心电图应变模式与心肌细胞扩张和弥漫性间质纤维化相关:一项多参数心脏磁共振研究。
Eur Heart J Cardiovasc Imaging. 2017 Apr 1;18(4):441-450. doi: 10.1093/ehjci/jew117.
10
Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.系统性硬化症患者存在亚临床心肌炎症和弥漫性纤维化——一项采用心肌 T1 mapping 和细胞外容积定量技术的临床研究。
J Cardiovasc Magn Reson. 2014 Mar 4;16(1):21. doi: 10.1186/1532-429X-16-21.

引用本文的文献

1
Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?生物活性食物成分能否有助于预防囊性纤维化相关心血管疾病?
Nutrients. 2023 Jan 8;15(2):314. doi: 10.3390/nu15020314.
2
Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study.高剂量白细胞介素-2治疗的急慢性心肺效应:一项磁共振成像观察性研究
Diagnostics (Basel). 2022 May 30;12(6):1352. doi: 10.3390/diagnostics12061352.

本文引用的文献

1
Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart Failure.慢性阻塞性肺疾病与心力衰竭关联的潜在机制。
JACC Cardiovasc Imaging. 2021 Oct;14(10):1963-1973. doi: 10.1016/j.jcmg.2021.03.026. Epub 2021 May 19.
2
Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance.采用心肺磁共振评估嗜酸性肉芽肿性多血管炎的心肌受累情况。
Int J Cardiovasc Imaging. 2021 Apr;37(4):1371-1381. doi: 10.1007/s10554-020-02091-1. Epub 2020 Nov 19.
3
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.
慢性肾脏损伤患者的冠状动脉微血管功能障碍、左心室重构和临床转归。
Circulation. 2020 Jan 7;141(1):21-33. doi: 10.1161/CIRCULATIONAHA.119.043916. Epub 2019 Nov 29.
4
Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.ST 段抬高型心肌梗死中冠状动脉微血管功能障碍的病理生理学和诊断。
Cardiovasc Res. 2020 Mar 1;116(4):787-805. doi: 10.1093/cvr/cvz301.
5
Association of Cardiovascular Disease With Respiratory Disease.心血管疾病与呼吸疾病的关联。
J Am Coll Cardiol. 2019 May 7;73(17):2166-2177. doi: 10.1016/j.jacc.2018.11.063. Epub 2019 Mar 4.
6
Cystic fibrosis survival: the changing epidemiology.囊性纤维化存活率:不断变化的流行病学。
Curr Opin Pulm Med. 2018 Nov;24(6):574-578. doi: 10.1097/MCP.0000000000000520.
7
Young patients with cystic fibrosis demonstrate subtle alterations of the cardiovascular system.年轻的囊性纤维化患者表现出心血管系统的细微改变。
J Cyst Fibros. 2018 Sep;17(5):643-649. doi: 10.1016/j.jcf.2017.12.009. Epub 2018 Feb 3.
8
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).临床推荐意见:心血管磁共振 T1、T2、T2* 和细胞外容积mapping:心血管磁共振学会(SCMR)的共识声明,得到欧洲心血管影像协会(EACVI)的认可。
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. doi: 10.1186/s12968-017-0389-8.
9
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome.心肌纤维化与射血分数保留的心力衰竭的时间关系:与基线疾病严重程度和随后的结局的关联。
JAMA Cardiol. 2017 Sep 1;2(9):995-1006. doi: 10.1001/jamacardio.2017.2511.
10
Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases.多参数心脏磁共振成像在心肌炎和全身性炎症性疾病中的临床应用
Int J Cardiovasc Imaging. 2018 Jan;34(1):35-54. doi: 10.1007/s10554-017-1063-9. Epub 2017 Jan 27.